Dear Colleagues,
Neurodegenerative diseases are a group of heterogeneous disorders caused by progressive neuron degeneration in the brain or peripheral nervous system. They affect patient quality of life and form serious health and economic burdens to affected subjects, their families and society. Alzheimer's disease (AD) and Parkinson's disease (PD) are among the most common neurodegenerative disorders. Most human neurodegenerative diseases are closely linked to aging. With the aging of our population, the prevalence of neurodegenerative diseases increases significantly, posing serious challenges worldwide. While oxidative stress, protein aggregation, mitochondria impairment, disturbance of autophagic clearance and adverse neuroinflammation are recognized as key factors in neurodegeneration, the complete understanding of disease pathogenesis remains elusive. As of now, neurodegenerative diseases remain chronic and incurable conditions. Currently, there are no available therapies that can alleviate the progressive degeneration of neurons in patients. Neurodegenerative diseases are among the leading causes of human death. This situation is unacceptable, underscoring the need for extensive future research in this area. The identification and validation of biomarkers and therapeutic targets are vital, as new biomarkers and therapeutic targets can enhance our clinical practice of diagnosis, prognosis, and therapy development for these formidable disorders.
The aim of this Special Issue is to discuss novel disease biomarkers and molecular therapeutic targets that aim to protect against or alleviate neurodegeneration in human neurodegenerative disorders.
Dr. Zhi Dong Zhou
Guest Editor
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.